151 related articles for article (PubMed ID: 34254153)
21. Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen.
Carrera-García L; Muchart J; Lazaro JJ; Expósito-Escudero J; Cuadras D; Medina J; Bosch de Basea M; Colomer J; Jimenez-Mallebrera C; Ortez C; Natera-de Benito D; Nascimento A
Eur J Paediatr Neurol; 2021 Mar; 31():92-101. PubMed ID: 33711792
[TBL] [Abstract][Full Text] [Related]
22. Nusinersen by subcutaneous intrathecal catheter for symptomatic spinal muscular atrophy patients with complex spine anatomy.
Carson VJ; Young M; Brigatti KW; Robinson DL; Reed RM; Sohn J; Petrillo M; Farwell W; Miller F; Strauss KA
Muscle Nerve; 2022 Jan; 65(1):51-59. PubMed ID: 34606118
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience.
Haché M; Swoboda KJ; Sethna N; Farrow-Gillespie A; Khandji A; Xia S; Bishop KM
J Child Neurol; 2016 Jun; 31(7):899-906. PubMed ID: 26823478
[TBL] [Abstract][Full Text] [Related]
24. Anesthetic management of pediatric patients undergoing intrathecal nusinersen administration for treatment of spinal muscular atrophy: A single-center experience.
Brollier LD; Matuszczak M; Marri T; Carbajal JG; Moorman AT; Sorial EM; Jain R
Paediatr Anaesth; 2021 Feb; 31(2):160-166. PubMed ID: 32623818
[TBL] [Abstract][Full Text] [Related]
25. Scoliosis and spinal muscular atrophy in the new world of medical therapy: providing lumbar access for intrathecal treatment in patients previously treated or undergoing spinal instrumentation and fusion.
Labianca L; Weinstein SL
J Pediatr Orthop B; 2019 Jul; 28(4):393-396. PubMed ID: 30932967
[TBL] [Abstract][Full Text] [Related]
26. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
[TBL] [Abstract][Full Text] [Related]
27. A Systematic Review of Procedural Complications from Transforaminal Lumbar Puncture for Intrathecal Nusinersen Administration in Patients with Spinal Muscular Atrophy.
Grayev A; Schoepp M; Kuner A
AJNR Am J Neuroradiol; 2021 May; 42(5):980-985. PubMed ID: 33632735
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound-guided interlaminar approach for nusinersen administration in patients with spinal muscular atrophy with spinal fusion or severe scoliosis.
Wei C; Liang Z; Wu Y; Liu S; Qiu J; Meng L; Li C; Li S; Bao X; Wang Z; Chen L; Xiong H
Orphanet J Rare Dis; 2023 Feb; 18(1):30. PubMed ID: 36800969
[TBL] [Abstract][Full Text] [Related]
29. Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity. Feasibility, safety and radiation exposure considerations.
Spiliopoulos S; Reppas L; Zompola C; Palaiodimou L; Papadopoulou M; Filippiadis D; Palialexis K; Ploussi A; Efstathopoulos E; Tsivgoulis G; Brountzos E
Eur J Neurol; 2020 Jul; 27(7):1343-1349. PubMed ID: 32250518
[TBL] [Abstract][Full Text] [Related]
30. Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model.
MacCannell D; Berger Z; Kirschner J; Mercuri E; Farrar MA; Iannaccone ST; Kuntz NL; Finkel RS; Valente M; Muntoni F
CNS Drugs; 2022 Feb; 36(2):181-190. PubMed ID: 35080757
[TBL] [Abstract][Full Text] [Related]
31. Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience.
Veerapandiyan A; Eichinger K; Guntrum D; Kwon J; Baker L; Collins E; Ciafaloni E
Muscle Nerve; 2020 Feb; 61(2):222-226. PubMed ID: 31773738
[TBL] [Abstract][Full Text] [Related]
32. Unilateral interlaminar fenestration on the convex side provides a reliable access for intrathecal administration of nusinersen in spinal muscular atrophy: a retrospective study.
Wang Z; Feng E; Jiao Y; Zhao J; Chen X; Zhang H; Liang J; Li Z; Cui X; Chen W; Shen J
Orphanet J Rare Dis; 2023 Nov; 18(1):369. PubMed ID: 38031122
[TBL] [Abstract][Full Text] [Related]
33. Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy.
Cordts I; Deschauer M; Lingor P; Burian E; Baum T; Zimmer C; Maegerlein C; Sollmann N
Sci Rep; 2020 Feb; 10(1):3406. PubMed ID: 32099042
[TBL] [Abstract][Full Text] [Related]
34. Transforaminal lumbar puncture for spinal anesthesia or novel drug administration: a technique combining C-arm fluoroscopy and ultrasound.
Berde C; Formanek A; Khan A; Camelo CR; Koka A; Riley BL; Padua H
Reg Anesth Pain Med; 2022 Jun; 47(6):380-383. PubMed ID: 35321920
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach.
Bortolani S; Stura G; Ventilii G; Vercelli L; Rolle E; Ricci F; Bergui M; Mongini T
Neuromuscul Disord; 2019 Oct; 29(10):742-746. PubMed ID: 31604650
[TBL] [Abstract][Full Text] [Related]
36. Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal Administrations.
Luu KT; Norris DA; Gunawan R; Henry S; Geary R; Wang Y
J Clin Pharmacol; 2017 Aug; 57(8):1031-1041. PubMed ID: 28369979
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy.
Cordts I; Lingor P; Friedrich B; Pernpeintner V; Zimmer C; Deschauer M; Maegerlein C
Ther Adv Neurol Disord; 2020; 13():1756286419887616. PubMed ID: 32010224
[TBL] [Abstract][Full Text] [Related]
38. Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy.
Oldenburg D; Guberina N; Stolte B; Kizina K; Stenzel E; Radbruch A; Kleinschnitz C; Hagenacker T; Forsting M; Mönninghoff C
Neuroradiology; 2019 May; 61(5):565-574. PubMed ID: 30868184
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
[TBL] [Abstract][Full Text] [Related]
40. Laboratory monitoring of nusinersen safety.
Goedeker NL; Gibbons JL; Varadhachary AS; Connolly AM; Zaidman CM
Muscle Nerve; 2021 Jun; 63(6):902-905. PubMed ID: 33675054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
